Publications
Vous trouverez ci-dessous la liste des publications dans lesquelles un chercheur de l’équipe figure en tant que premier ou dernier auteur.
Anti-interleukin 5 for treating severe refractory vernal keratoconjunctivitis in children: Two cases
16/05/2024
Another case of occupational hand allergic contact dermatitis to benzyl alcohol in an epoxy floor paint
08/05/2024
Early exposure to sunlight and allergic morbidity: The PARIS birth cohort
18/04/2024
Uranium contamination of bivalve Mytilus galloprovincialis, speciation and localization
12/04/2024
Radiation protection in a cohort of healthcare workers: knowledge, attitude, practices, feelings and IR-exposure in French hospitals
03/04/2024
Case Report: A family history of peanut allergy and hereditary alpha-tryptasemia
08/02/2024
Three-dimensional printing: A new source of exposure to (meth)acrylates in a dental technician
02/02/2024
Pubertal origin of growth retardation in inborn errors of protein metabolism: A longitudinal cohort study
14/01/2024
Acute and repeated exposures of normal human bronchial epithelial (NHBE) cells culture to particles from a coloured pyrotechnic smoke
25/11/2023
Guidelines for cold urticaria management, established by the Centre of Evidence of Dermatology and the Urticaria Group of the French Society of Dermatology
24/11/2023
Unsupervised identification of cardiometabolic profiles among adolescents: findings from the PARIS birth cohort study
18/11/2023
Short message service as a tool for mass follow-up of patients requesting a poison centre: a retrospective comparative study in France
13/11/2023
G protein-coupled receptor 17 is regulated by WNT pathway during oligodendrocyte precursor cell differentiation
02/10/2023
KIT Mutations and Other Genetic Defects in Mastocytosis: Implications for Disease Pathology and Targeted Therapies
27/09/2023
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT
12/08/2023
Omalizumab for severe allergic keratoconjunctivitis: A case series
23/07/2023
Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU/mL
19/06/2023
Subgroups of perceptions and related behaviors during the COVID-19 lockdown: experience of adolescents in the PARIS birth cohort
11/05/2023